# Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia

> **NCT04619719** · NA · TERMINATED · sponsor: **Legacy Health System** · enrollment: 27 (actual)

## Conditions studied

- Covid19

## Interventions

- **DEVICE:** Hyperbaric Oxygen Therapy (HBOT)

## Key facts

- **NCT ID:** NCT04619719
- **Lead sponsor:** Legacy Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-15
- **Primary completion:** 2022-01-27
- **Final completion:** 2023-02-09
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Lack of patients
- **Last updated:** 2023-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04619719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04619719, "Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04619719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*